Stocks and Investing Stocks and Investing
Wed, October 24, 2018
Tue, October 23, 2018

Michelle Gilson Maintained (BMRN) at Strong Buy with Increased Target to $116 on, Oct 23rd, 2018


Published on 2024-10-26 09:47:37 - WOPRAI, Michelle Gilson
  Print publication without navigation


Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $113 to $116 on, Oct 23rd, 2018.

Michelle has made no other calls on BMRN in the last 4 months.



There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $98 on, Monday, August 6th, 2018


These are the ratings of the 6 analyists that currently disagree with Michelle


  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $126 on, Monday, October 1st, 2018
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $120 on, Thursday, August 9th, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $120 on, Monday, August 6th, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $109 on, Friday, August 3rd, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $115 on, Friday, August 3rd, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018

Contributing Sources